Emoxypine
| Clinical data | |
|---|---|
| Trade names | Mexidol |
| Other names | Emoxipine, Emoxypin, Epigid, 6-Methyl-2-ethyl-3-hydroxypyridine |
| Routes of administration | Oral & IV |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 2-2.6 h |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.205.098 |
| Chemical and physical data | |
| Formula | C8H11NO |
| Molar mass | 137.182 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 170 to 172 °C (338 to 342 °F) [1] |
SMILES
| |
InChI
| |
| (verify) | |
Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine), also known as Mexidol or Mexifin, a succinate salt, is chemical compound which is claimed by its manufacturer, the Russian company Pharmasoft Pharmaceuticals, to have antioxidant and actoprotector properties,[2][3] but these purported properties of emoxypine have not been proven.[4] Its chemical structure resembles that of pyridoxine (a type of vitamin B6).
- ^ Gruber W (1953). "Synthesis of 3-Hydroxy-2-alkylpyridines". Canadian Journal of Chemistry. 31 (6): 564–568. doi:10.1139/v53-079.
- ^ "mexidol.ru, Pharmasoft Website". Archived from the original on 2011-04-10. Retrieved 2011-04-27.
- ^ Yakovlev IY (2013). "Механізми актопротекторної дії похідних янтарної кислоти" [Mechanisms of actoprotective action of succinic acid's derivatives]. Лікарська справа (in Ukrainian) (3): 78–85. PMID 25016753.
- ^ Cite error: The named reference
pmid17117675was invoked but never defined (see the help page).